Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGER4 | P35408 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | DCAF1 | Q9Y4B6 | 1/20 | 0.38 |
| ▸ | SCN9A | Q15858 | 4/20 | 0.38 |
| ▸ | GRM5 | P41594 | 1/20 | 0.37 |
| ▸ | IKBKB | O14920 | 1/20 | 0.37 |
| ▸ | NUDT1 | P36639 | 1/20 | 0.36 |
| ▸ | MAOB | P27338 | 1/20 | 0.36 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.36 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.36 |
| ▸ | BTK | Q06187 | 1/20 | 0.35 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.35 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.35 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.35 |
| ▸ | IDO1 | P14902 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3325668 | 0.91 | POLB (0.38) | PTGER4POLBSCN9ACHRM3 | |
| SCHEMBL1763152 | 0.88 | CSNK1E (0.43) | POLB | |
| SCHEMBL1762661 | 0.85 | HSD17B10 (0.38) | PTGER4POLBSCN9ACHRM1MAPT | |
| SCHEMBL1762650 | 0.85 | ALDH1A1 (0.39) | PTGER4MAPT | |
| SCHEMBL1762883 | 0.83 | POLB (0.38) | POLBGRM5 | |
| SCHEMBL1762849 | 0.83 | HSD17B10 (0.44) | POLBSCN9AIKBKBMAPT | |
| SCHEMBL3232405 | 0.82 | CSNK1D (0.41) | PTGER4POLBSCN9ANUDT1 | |
| SCHEMBL1763063 | 0.82 | MGLL (0.38) | POLBCHRM3 | |
| SCHEMBL28430781 | 0.80 | POLB (0.41) | PTGER4POLBDCAF1SCN9AMAPT | |
| SCHEMBL28248772 | 0.80 | POLB (0.51) | POLBGRM5GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8263327-B2 | Enzymatic method for the production of microcapsules | BASF SE (DE) | 2012-09-11 | — | — | US | disclosed |
| US-20110124590-A1 | Oil-in-Water Emulsion Comprising Solvent, Water, Surfactant and Pesticide | BASF SE (DE) | 2011-05-26 | — | — | US | disclosed |
| US-20100120617-A1 | Enzymatic Method for the Production of Microcapsules | BASF SE | 2010-05-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100120617-A1 | Enzymatic Method for the Production of Microcapsules | MGAM, ACHE, BCHE | PTGER4 3258/4885POLB 565/4885DCAF1 1702/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.